Cannabis Science, the San Francisco company dedicated to developing medicines derived from marijuana, filled in a bit more detail on why it fired former Chief Executive Steve Kubby last week in a filing today with the SEC. The company has authorized an internal investigation and “review by counsel” of Kubby’s “apparently fraudulent Read the rest of this entry »
The board of Cannabis Science, the San Francisco research and development firm aiming to develop medicines derived from marijuana, resolved today to “immediately remove and terminate all corporate contracts” with Chief Executive Steven Kubby. Without citing specific instances, the board resolution said Kubby (pictured) Read the rest of this entry »
As part of an effort to raise its profile, Cannabis Science, the San Francisco research and development firm aiming to develop cannabis-based medicines, has hired a Canadian company to provide it with investor relations services. In April, Cannabis got the OK from the U.S. Financial Industry Regulatory Authority to begin trading its shares over the counter under the symbol CBIS.
Earlier this month the company touted the fact that it had received Read the rest of this entry »
Subscribe via RSS all feeds